<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02769442</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00068278</org_study_id>
    <nct_id>NCT02769442</nct_id>
  </id_info>
  <brief_title>Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED</brief_title>
  <official_title>Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Terumo Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized prospective comparison of two FDA approved intravenous catheters in the
      emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise
      to increase intravenous access success rates and decrease blood contamination of the
      insertion site. This study would analyze these properties in our busy, urban emergency
      department setting where time and safety of intravenous access are most critical.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rational for the Study Emergency department (ED) patients frequently require rapid,
      short-term intravenous (IV) access for diagnosis and treatment of emergency medical
      conditions. IV access can be uncomfortable and painful for the patient. Therefore ensuring
      first attempt success is important. Furthermore, given the time-sensitive nature of emergent
      medical conditions, immediate success helps to minimize delay in analgesic medication
      administration, resuscitation and therapeutic interventions. The process of obtaining IV
      access has the potential for operator exposure to blood-borne pathogens. After a tourniquet
      is placed on an extremity, positive venous pressure forces blood out of the catheter until a
      lure lock can be applied. Traditional IV catheters require the operator to kink the catheter
      and apply pressure to the body of the catheter to mitigate the degree of blood leakage while
      simultaneously connecting the lure lock. This is a complicated process that often leads to
      blood contamination of the insertion site, and the environment, including the potential for
      blood spillage on the bedding, ground or the operator. In addition to the potential for
      blood-born pathogen exposures, this spillage leads to further patient care delays, as it
      requires prompt cleaning.

      Terumo Medical Corp., a leading manufacturer of medical devices, has introduced a novel IV
      access catheter (which is already FDA approved) with features that promise to increase first
      attempt success and decrease blood contamination during the insertion process. The Terumo
      SurFlash Plus catheter has a technology that produces a visible flash of blood at the end of
      the catheter when the needle is placed in the vessel and a second flash between the catheter
      and the needle which confirms proper catheter placement in the vein. Furthermore, this new
      catheter has a proprietary safety valve that minimizes the risk of blood exposure between
      needle removal and IV lure lock attachment.

      This study would analyze these unique properties (first skin puncture success and insertion
      site blood contamination) in a high volume, urban emergency department where time and safety
      of IV access are critical.

      Purpose of Study Primary Objective: Compare the rate of first-skin puncture success using the
      Terumo SurFlash Plus compared with the BD Insyte Autoguard.

      Secondary Objective: Compare the frequency and severity of blood contamination of the
      insertion site between the two aforementioned devices.

      Research Design This will be a prospective, randomized controlled study of the Terumo
      SurFlash Plus IV catheter versus the current standard ED IV catheter (BD Insyte Autoguard).

      Study device: The Terumo SurFlash Plus catheter is FDA approved and already used at multiple
      medical centers in the United States. Gauge sizes 18, 20 and 22 will be provided by TERUMO to
      the ED at no cost to the hospital.

      IV inserters (operators) will be Mercy Medical Center emergency department technicians,
      nurses and providers who routinely obtain IV access in the ED.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With First-skin Puncture Success</measure>
    <time_frame>Within first minute of IV access</time_frame>
    <description>First attempt success, defined as one skin puncture (redirection permitted) which allows for completion of a blood draw and/or flush without extravasation.
Gauge size
Patient prior history of difficult IV access
Operator type (ED Technician/Registered Nurse/Physician Assistant/Nurse Practitioner/Resident/Attending)
Operator years of experience with IV access
Type of catheter used</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Blood Visible at Site of Insertion</measure>
    <time_frame>Within first minute of IV access</time_frame>
    <description>Compare the frequency of bleeding near the insertion site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Catheters</condition>
  <condition>Catheterization, Peripheral</condition>
  <arm_group>
    <arm_group_label>Terumo SurFlash Plus catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the Terumo catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BD Insyte Autoguard catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the BD catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Terumo SurFlash Plus catheter</intervention_name>
    <arm_group_label>Terumo SurFlash Plus catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BD Insyte Autoguard catheter</intervention_name>
    <arm_group_label>BD Insyte Autoguard catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult ED patient requiring an IV for clinical care

          -  Hemodynamically stable: pulse &gt;50 and &lt;130, MAP&gt;60

          -  Willing to read (or be read to) the informed consent and participate in study

        Exclusion Criteria:

          -  Medically unstable

          -  Agitated or psychiatrically unstable

          -  Lacking capacity to consent, such as with altered mental status.

          -  Unable to speak and read English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siamak Moayedi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.youtube.com/watch?v=5ww5tgnPuXg</url>
    <description>Youtube video describing Terumo SurFlash Plus catheter</description>
  </link>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 9, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <results_first_submitted>February 7, 2018</results_first_submitted>
  <results_first_submitted_qc>May 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 6, 2018</results_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, Baltimore</investigator_affiliation>
    <investigator_full_name>Siamak Moayedi, MD</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Intravenous</keyword>
  <keyword>Catheter</keyword>
  <keyword>Puncture</keyword>
  <keyword>Peripheral Catheterization</keyword>
  <keyword>First Stick Success</keyword>
  <keyword>Contamination</keyword>
  <keyword>Terumo</keyword>
  <keyword>SurFlash</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Terumo SurFlash Plus Catheter</title>
          <description>Patients randomized to the Terumo catheter</description>
        </group>
        <group group_id="P2">
          <title>Becton Dickinson (BD) Insyte Autoguard Catheter</title>
          <description>Patients randomized to the Becton Dickinson (BD) catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="309"/>
                <participants group_id="P2" count="291"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="309"/>
                <participants group_id="P2" count="291"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Terumo SurFlash Plus Catheter</title>
          <description>Patients randomized to the Terumo catheter</description>
        </group>
        <group group_id="B2">
          <title>BD Insyte Autoguard Catheter</title>
          <description>Patients randomized to the BD catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="309"/>
            <count group_id="B2" value="291"/>
            <count group_id="B3" value="600"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Patient Age Mean</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="309"/>
                    <count group_id="B2" value="291"/>
                    <count group_id="B3" value="600"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.1" spread="17.7"/>
                    <measurement group_id="B2" value="50.9" spread="17.7"/>
                    <measurement group_id="B3" value="51" spread="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="309"/>
                    <count group_id="B2" value="291"/>
                    <count group_id="B3" value="600"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="201"/>
                    <measurement group_id="B2" value="175"/>
                    <measurement group_id="B3" value="376"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="108"/>
                    <measurement group_id="B2" value="116"/>
                    <measurement group_id="B3" value="224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With First-skin Puncture Success</title>
        <description>First attempt success, defined as one skin puncture (redirection permitted) which allows for completion of a blood draw and/or flush without extravasation.
Gauge size
Patient prior history of difficult IV access
Operator type (ED Technician/Registered Nurse/Physician Assistant/Nurse Practitioner/Resident/Attending)
Operator years of experience with IV access
Type of catheter used</description>
        <time_frame>Within first minute of IV access</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Terumo SurFlash Plus Catheter</title>
            <description>Patients randomized to the Terumo catheter</description>
          </group>
          <group group_id="O2">
            <title>BD Insyte Autoguard Catheter</title>
            <description>Patients randomized to the BD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With First-skin Puncture Success</title>
          <description>First attempt success, defined as one skin puncture (redirection permitted) which allows for completion of a blood draw and/or flush without extravasation.
Gauge size
Patient prior history of difficult IV access
Operator type (ED Technician/Registered Nurse/Physician Assistant/Nurse Practitioner/Resident/Attending)
Operator years of experience with IV access
Type of catheter used</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="309"/>
                <count group_id="O2" value="291"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244"/>
                    <measurement group_id="O2" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Blood Visible at Site of Insertion</title>
        <description>Compare the frequency of bleeding near the insertion site</description>
        <time_frame>Within first minute of IV access</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Terumo SurFlash Plus Catheter</title>
            <description>Patients randomized to the Terumo catheter</description>
          </group>
          <group group_id="O2">
            <title>BD Insyte Autoguard Catheter</title>
            <description>Patients randomized to the BD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Blood Visible at Site of Insertion</title>
          <description>Compare the frequency of bleeding near the insertion site</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="309"/>
                <count group_id="O2" value="291"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 hours or less depending on duration of emergency department stay</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Terumo SurFlash Plus Catheter</title>
          <description>Patients randomized to the Terumo catheter</description>
        </group>
        <group group_id="E2">
          <title>BD Insyte Autoguard Catheter</title>
          <description>Patients randomized to the BD catheter</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="309"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="291"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="309"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="291"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="309"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="291"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Siamak Moayedi Md</name_or_title>
      <organization>University of Maryland School of Medicine, Department of Emergency Medicine</organization>
      <phone>4103288025</phone>
      <email>smoayedi@em.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

